Why Biogen's FDA Approval Is Shocking
Many doctors don't like the drug, and the trial data was underwhelming. Nonetheless, Biogen's Alzheimer's drug was approved-- and the market opportunity is huge.
Full Article
Why Biogen's FDA Approval Is Shocking
Motley Fool
0 shares
1 views
You might like
Related news coverage
-
Two House committees to investigate FDA's approval of Biogen's Alzheimer's drug
SeekingAlpha
-
Lilly to seek FDA approval for potential Alzheimer's drug
SeattlePI.com
-
How the new Alzheimer’s disease drug could influence future research
Upworthy
-
Another Biogen Alzheimer's drug expedited by the FDA
bizjournals
Advertisement
More coverage
Top stock stories from Wednesday: Microsoft hits milestone valuation, Amazon details green strategy, Shake Shack expands in China
Invezz
U.S. FDA struggles with Biogen’s Alzheimer drug’s approval The U.S. Food and Drug Administration (FDA) met with disagreements..
-
FDA documents show struggle over approval of new Alzheimer’s drug from Biogen
Indian Express
-
Biogen won approval for Alzheimer’s therapy while FDA staff raised concerns - WSJ
SeekingAlpha
-
FDA officials should resign over 'reckless' approval of Biogen Alzheimer’s drug, says US consumer rights group
Proactive Investors
-
Public Citizen demands removal of top FDA officials over Biogen Alzheimer's approval
SeekingAlpha